Particularly, the thioredoxin/glutaredoxin (Trx/Grx) systems, which are the key cellular disulfide reductase system, play critical roles in NAFLD and may act as molecular targets for NAFLD, providing insight for the treatment of NAFLD. This evidence concerns the gene GLRX and metabolic dysfunction-associated steatotic liver disease.